pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,416 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: filing×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07260279: Effect of an Educational Session for Abortive Women on Maternity Nurses' Practices

Sponsor: Mansoura University. Phase: NA. Conditions: Abortion, Practice, Maternity

full page →ctgov ↗
›COMPLETEDphase readoutNCT03136679: Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

Sponsor: Baylor Research Institute. Phase: . Conditions: Mild Cognitive Impairment, Alzheimer Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07355062: A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

Sponsor: Renibus Therapeutics, Inc.. Phase: PHASE3. Conditions: CKD, Metabolic Acidosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05953662: Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Colorectal Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT06723262: Speech Perception of a Tonotopy-based Fitting for Cochlear Implant Recipients for 6 Months With Conventional Setting

Sponsor: MED-EL Elektromedizinische Geräte GesmbH. Phase: NA. Conditions: Sensorineural Hearing Loss, Bilateral

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07575646: Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective Enamel Etching

Sponsor: Cairo University. Phase: NA. Conditions: Cervical Caries

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07548346: MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Sponsor: Middle East North Africa Stroke and Interventional Neurotherapies Organization. Phase: NA. Conditions: Cerebral Venous Sinus Thrombosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07405346: A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: NA. Conditions: Advanced Leiomyosarcoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02782546: Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04870788: Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Advanced Malignant Solid Neoplasm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07548788: A Lay Navigation Intervention for Patients With Lung Cancer

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC), Patient Navigation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07657403: CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Brain Neoplasms, Eloquent Area Brain Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT02689427: Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07493642: Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

Sponsor: Fu Jen Catholic University Hospital. Phase: NA. Conditions: Chronic Kidney Disease (CKD), CKD Stage 1-3

full page →ctgov ↗
›RECRUITINGphase readoutNCT04953273: A Case Management Algorithm for Women Victims of Violence

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Post-Traumatic Stress Disorder, Violence-Related Symptom

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07661173: A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer

Sponsor: Anhui Provincial Cancer Hospital. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05503069: Community Interventions to Improve Breastfeeding

Sponsor: University of Mississippi Medical Center. Phase: NA. Conditions: Breastfeeding, Breastfeeding, Exclusive

full page →ctgov ↗
›RECRUITINGphase readoutNCT03407469: Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Cancer-related Venous Thromboembolism

full page →ctgov ↗
›COMPLETEDphase readoutNCT07360483: Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery

Sponsor: Cairo University. Phase: NA. Conditions: Hypertrophic Scars

full page →ctgov ↗
›COMPLETEDphase readoutNCT03229083: Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

Sponsor: University of Rochester. Phase: NA. Conditions: Advanced Renal Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06411054: The Efficacy of Acu-TENS as an Adjunct Analgesic During USG-MVA

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Pain, Acute

full page →ctgov ↗
›RECRUITINGphase readoutNCT05078905: Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: COVID-19, Vaccination, Healthy Volunteer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06456905: Automated Reinforcement Management Systems, Phase II

Sponsor: Washington State University. Phase: NA. Conditions: Alcohol Use Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07444905: Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

Sponsor: Tongji Hospital. Phase: . Conditions: HCC - Hepatocellular Carcinoma, Machine Learning, Evaluation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07352605: Percutaneous Drainage Versus Antibiotic Therapy for Acute Diverticulitis With Abscess.

Sponsor: Azienda Sanitaria di Firenze. Phase: NA. Conditions: Diverticular Disease of Colon

full page →ctgov ↗
›RECRUITINGphase readoutNCT07221266: Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

Sponsor: University of Texas, El Paso. Phase: NA. Conditions: Parkinson Disease (PD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT00455156: Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

Sponsor: Premier Research. Phase: PHASE3. Conditions: Contraception

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07511166: A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.. Phase: . Conditions: Atrial Fibrillation

full page →ctgov ↗
›COMPLETEDphase readoutNCT05287256: Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

Sponsor: Johns Hopkins University. Phase: PHASE1. Conditions: Behavioral Pharmacology of Cannabis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05678322: Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Sponsor: NYU Langone Health. Phase: PHASE3. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07382622: Effect of JointIQ on Joint Discomfort in Healthy Subjects

Sponsor: Chung Shan Medical University. Phase: NA. Conditions: Joint Discomfort

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07056322: Optimal Meals to Reduce Bone Resorption in Women With Osteopenia

Sponsor: University of Aarhus. Phase: NA. Conditions: Osteopenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552220: Muscle Imaging Project Using ANatomopathology and Full Field Optical Coherence Tomography

Sponsor: Centre Hospitalier de Mâcon. Phase: . Conditions: Myositis, Health Adult Subjects

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06635824: Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

Sponsor: Genmab. Phase: PHASE3. Conditions: PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06373380: A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: HPV16+ Squamous Cell Carcinoma

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06364280: Pediatric Prehospital Airway Resuscitation Trial

Sponsor: Ohio State University. Phase: NA. Conditions: Heart Arrest, Out-Of-Hospital, Wounds and Injuries, Respiratory Insufficiency in Children, Child, Only, Critical Illness

full page →ctgov ↗
›RECRUITINGphase readoutNCT07290296: Popliteus Muscle Release Versus Kinesio Taping

Sponsor: Cairo University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07612696: Impact of Electronic Cigarette Temperature and Solvent on Biomarkers

Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Oxidative Stress, Tobacco Use, Electronic Cigarettes

full page →ctgov ↗
›RECRUITINGphase readoutNCT04406662: Routine Evaluation of People Living With Cancer

Sponsor: University of Edinburgh. Phase: . Conditions: Cachexia; Cancer, Advanced Cancer, Quality of Life

full page →ctgov ↗
›COMPLETEDphase readoutNCT07639762: Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures

Sponsor: Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Phase: . Conditions: Hip Fracture, Pain Management, Multimodal Analgesia, Peripheral Nerve Block, Lumbar Erector Spinae Plane Block, Suprainguinal Fasia Iliaca Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT07108062: Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

Sponsor: Hungarian University of Sports Science. Phase: NA. Conditions: Enuresis Nocturnal, Urinary Incontinence

full page →ctgov ↗
›COMPLETEDphase readoutNCT06295562: Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea

Sponsor: China Medical University Hospital. Phase: PHASE4. Conditions: Obstructive Sleep Apnea of Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07098962: KinesioTaping for Thoracic Drain Support

Sponsor: Kastamonu University. Phase: PHASE2. Conditions: Primary Condition: Pain, Postoperative, Associated Conditions: Cardiac Surgical Procedures, Thoracic Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01783288: Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening

Sponsor: Vanderbilt University. Phase: NA. Conditions: Postural Tachycardia Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07644403: Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd. Phase: PHASE1. Conditions: Epithelial Cancer Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07465627: Vessel Recoil in Specific CLTI Populations

Sponsor: Medical University of Graz. Phase: . Conditions: Chronic Limb Threatening Ischemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06553027: To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Sponsor: Cerevance. Phase: PHASE3. Conditions: Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07541261: A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia

Sponsor: Janssen Research & Development, LLC. Phase: . Conditions: Colitis, Ulcerative, Crohn Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06954961: A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer

Sponsor: InventisBio Co., Ltd. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05617742: Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Lung Cancer

full page →ctgov ↗
← prev
page 79 of 109
next →